Indium in-111 pentetreotide kit - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for indium in-111 pentetreotide kit and what is the scope of patent protection?

Indium in-111 pentetreotide kit is the generic ingredient in two branded drugs marketed by Sun Pharm Inds Inc and Curium, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for indium in-111 pentetreotide kit

US Patents:	0
Tradenames:	2
Applicants:	2
NDAs:	2
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	6
Clinical Trials:	5
DailyMed Link:	indium in-111 pentetreotide kit at DailyMed

Recent Clinical Trials for indium in-111 pentetreotide kit

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University Hospital Inselspital, Berne	Phase 1/Phase 2
University Hospital, Basel, Switzerland	Phase 1/Phase 2
University of Lausanne Hospitals	Phase 1/Phase 2

See all indium in-111 pentetreotide kit clinical trials

US Patents and Regulatory Information for indium in-111 pentetreotide kit

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Curium	OCTREOSCAN	indium in-111 pentetreotide kit	INJECTABLE;INJECTION	020314-001	Jun 2, 1994	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sun Pharm Inds Inc	INDIUM IN-111 PENTETREOTIDE KIT	indium in-111 pentetreotide kit	INJECTABLE;INJECTION	212785-001	Jul 1, 2024	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for indium in-111 pentetreotide kit

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Curium	OCTREOSCAN	indium in-111 pentetreotide kit	INJECTABLE;INJECTION	020314-001	Jun 2, 1994	⤷ Sign Up	⤷ Sign Up
Curium	OCTREOSCAN	indium in-111 pentetreotide kit	INJECTABLE;INJECTION	020314-001	Jun 2, 1994	⤷ Sign Up	⤷ Sign Up
Curium	OCTREOSCAN	indium in-111 pentetreotide kit	INJECTABLE;INJECTION	020314-001	Jun 2, 1994	⤷ Sign Up	⤷ Sign Up
Curium	OCTREOSCAN	indium in-111 pentetreotide kit	INJECTABLE;INJECTION	020314-001	Jun 2, 1994	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.